Driehaus Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-535,717
| Closed | -$6.31M | – | 420 |
|
|
2024
Q2 | $6.31M | Sell |
535,717
-5,821
| -1% | -$68.6K | 0.06% | 250 |
|
|
2024
Q1 | $6.42M | Sell |
541,538
-487,030
| -47% | -$5.78M | 0.06% | 267 |
|
|
2023
Q4 | $12.6M | Sell |
1,028,568
-6,055
| -0.6% | -$74.2K | 0.15% | 210 |
|
|
2023
Q3 | $9.96M | Sell |
1,034,623
-1,312
| -0.1% | -$12.6K | 0.13% | 208 |
|
|
2023
Q2 | $9.32M | Buy |
1,035,935
+20,816
| +2% | +$187K | 0.12% | 220 |
|
|
2023
Q1 | $7.98M | Buy |
1,015,119
+3,748
| +0.4% | +$29.5K | 0.11% | 246 |
|
|
2022
Q4 | $6.84M | Buy |
1,011,371
+481,932
| +91% | +$3.26M | 0.1% | 245 |
|
|
2022
Q3 | $7.68M | Buy |
+529,439
| New | +$7.68M | 0.12% | 227 |
|
|
2021
Q1 | – | Sell |
-50,000
| Closed | -$950K | – | 474 |
|
|
2020
Q4 | $950K | Buy |
+50,000
| New | +$950K | 0.02% | 327 |
|